AWM
RMD icon

Apollon Wealth Management’s ResMed RMD Stock Holding History

Apollon Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Sell
1,676
-208
-11% -$43.1K ﹤0.01% 1220
2026
Q1 		$423K Sell
1,884
-212
-10% -$52.8K 0.01% 942
2025
Q4 		$505K Buy
2,096
+126
+6% +$32.2K 0.01% 830
2025
Q3 		$539K Buy
1,970
+55
+3% +$15K 0.01% 798
2025
Q2 		$494K Buy
1,915
+429
+29% +$102K 0.01% 816
2025
Q1 		$333K Sell
1,486
-173
-10% -$40.4K 0.01% 922
2024
Q4 		$379K Buy
1,659
+208
+14% +$50.1K 0.01% 853
2024
Q3 		$354K Buy
1,451
+190
+15% +$42.5K 0.01% 855
2024
Q2 		$241K Buy
1,261
+36
+3% +$7.3K 0.01% 934
2024
Q1 		$243K Buy
1,225
+26
+2% +$4.76K 0.01% 953
2023
Q4 		$206K Buy
+1,199
New +$184K 0.01% 998

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CISOA
Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Apollon Wealth Management's RMD Position: Q2 2026 in Review

Apollon Wealth Management reduced its ResMed (RMD) stake by 11% in Q2 2026, selling an estimated $43.1K and leaving 1,676 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Apollon Wealth Management first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $539K in Q3 2025. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Apollon Wealth Management held 1,676 shares of ResMed worth $327K as of Q2 2026.
  • Apollon Wealth Management sold 208 ResMed shares in Q2 2026, an estimated $43.1K.
  • ResMed made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1220 holding.
  • Apollon Wealth Management first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Apollon Wealth Management's ResMed position peaked at $539K in Q3 2025.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.